“I’m pleased that we are living in times where progress is being made, and trials are being done because previously there weren’t trials specifically for low-grade serous cancer.” – Dr Susana Banerjee
UK Ovarian Cancer Support Charity Ovacome has published an excellent update on low-grade serous ovarian cancer with Dr Susana Banerjee – the UK lead for the Verastem Mek/Braf/FAK clinical trial. You can watch it below.
